MainAs a service to firms that wish to export pharmaceuticals to international markets, the Office of Compliance (OC) may issue a certificate that indicates the firm’s acceptable compliance status to the receiving country. Certificate requests may be approved and issued, returned for additional information, rejected, or withdrawn by the requestor. 1) As of April 30, 3011 this measure will no longer be reported on through FDA-TRACK.Number

Oct 2009827Nov 2009482Dec 2009418Jan 2010367Feb 2010291Mar 2010623Apr 2010524May 2010301Jun 2010238Jul 2010185Aug 2010324Sep 2010427

Oct 2010508Nov 2010534Dec 2010412Jan 2011500Feb 2011526Mar 2011730Apr 2011753http://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htmFDA-TRACK CDER DashboardMain1) As of April 30, 3011 this measure will no longer be reported on through FDA-TRACK.Number

Oct 2009810Nov 2009475Dec 2009416Jan 2010340Feb 201094Mar 2010598Apr 2010387May 2010154Jun 201087Jul 201086Aug 2010250Sep 2010112

Oct 2010162Nov 2010163Dec 2010113Jan 2011431Feb 201131Mar 2011142Apr 2011280 ਍††਍਍਍਍਍਍਍